A promising new treatment for Parkinson’s disease
Lixisenatide, a drug developed by Sanofi already used against type 2 diabetes, could slow the progression of Parkinson’s motor symptoms, according to a clinical trial carried out in patients with an early stage of the disease. A treatment has shown to slow the progression of… Read More